Keyword: Centers for Medicare & Medicaid Services
Guardant received an expanded Medicare determination for its Guardant360 test, broadening its coverage to all solid tumors outside of the CNS.
Fraudsters enlist health professionals to contact people they've never met by telephone or video chat under the guise of a telemedicine consultation.
Five years after Congress passed a law to reduce unnecessary MRIs and CT scans, federal officials have yet to implement it.
Medtronic walked away from Responsive Orthopedics, which it bought three years ago to disrupt the knee replacement market with cheaper joints.
The U.S. government has formed an interagency task force to guide the rapid deployment of in vitro diagnostic tests during public health emergencies.
Officials put the rule forward to enable earlier Medicare coverage of medical devices, only to withdraw it nine months later.
CMS covers traditional insulin pumps, but not tubeless patch pumps, causing concern around innovation as well as patient access.
F1CDx is an NGS-based test to detect alterations in 324 genes relevant to a range of solid tumors.
Hospitals enrolled in Medicare will soon receive reimbursement for HeartFlow's noninvasive technology for coronary artery disease analysis.
Theranos and Walgreens have reached a tentative agreement to put the latter's breach-of-contract lawsuit to rest, WSJ sources say.